Observational studyFukushima journal of medical science2026
The change in the proportion of positive cases of dengue fever and influenza tests before and after the first case of COVID-19 in Cambodia: a preliminary observational prospective descriptive study.
Observational study in Fukushima journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this study was to investigate the trends in the number of positive cases of influenza and dengue fever before and during the COVID-19 pandemic in a private hospital in Cambodia. This study was a preliminary observational prospective descriptive study. A total of 2,991 patients were included. The positivity rate for dengue fever was higher before COVID-19 (14.7%, 179/1217) than during the COVID-19 period (4.1%, 10/242). For influenza, the positivity rates before COVID-19 were 13.3% (185/1394) for influenza A and 10.7% (149/1394) for influenza B. During the COVID-19 period, these rates changed to 18.2% (174/958) for influenza A and 0.4% (4/958) for influenza B. A whole country assessment of dengue and influenza disease patients should be done during the COVID-19 pandemic term.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.